ChemoMetec A/S (0DZ0) Stock Statistics & Valuation Metrics

ChemoMetec A/S has a market cap or net worth of kr8.65B. The enterprise value is kr11.69K.

ChemoMetec A/S has 17,402,480 shares outstanding. The number of shares has decreased by -2.65% in one year.

ChemoMetec A/S’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 28.10%.

The current PE Ratio of ChemoMetec A/S is 48.4. ChemoMetec A/S’s PEG ratio is ―.

In the last 12 months, ChemoMetec A/S had revenue of 495.57M and earned 186.41M in profits. Earnings per share was 10.71.

In the last 12 months, operating cash flow was 210.08M and capital expenditures -30.85M, giving a free cash flow of 179.23M billion.

ChemoMetec A/S pays an annual dividend of ―, resulting in a dividend yield of ―

ChemoMetec A/S upcoming earnings date is Sep 10, 2026, TBA (Not Confirmed).

ChemoMetec A/S as a current ratio of 3.70, with Debt / Equity ratio of 0.80%

In the past 12 months, ChemoMetec A/S has paid 53.61M in taxes.

ChemoMetec A/S EV to EBITDA ratio is 39.71, with an EV/FCF ratio of 55.39.

ChemoMetec A/S has kr274.66M in cash and marketable securities with kr7.78M in debt, giving a net cash position of kr269.45M billion.

Gross margin is 80.29%, with operating margin of 49.98%, and net profit margin of 37.61%.

The average price target for ChemoMetec A/S is kr500.00, which is 11.43% higher than the current price. The consensus rating is Hold